ログイン
言語:

WEKO3

  • トップ
  • ランキング
To
lat lon distance
To

Field does not validate



インデックスリンク

インデックスツリー

メールアドレスを入力してください。

WEKO

One fine body…

WEKO

One fine body…

アイテム

  1. Public
  1. Public
  2. 国外雑誌論文

Urodynamic effects of α1-blocker tamsulosin on voiding dysfunction in patients with neurogenic bladder

https://asahikawa-med.repo.nii.ac.jp/records/718
https://asahikawa-med.repo.nii.ac.jp/records/718
f6b30faa-1dd8-498a-b2ef-9be69337193e
名前 / ファイル ライセンス アクション
898.pdf 898.pdf (260.0 kB)
Item type 学術雑誌論文 / Journal Article_02(1)
公開日 2008-03-28
タイトル
タイトル Urodynamic effects of α1-blocker tamsulosin on voiding dysfunction in patients with neurogenic bladder
言語 en
言語
言語 eng
資源タイプ
資源タイプ journal article
著者 柿崎, 秀宏

× 柿崎, 秀宏

柿崎, 秀宏

ja-Kana カキザキ, ヒデヒロ

Search repository
Ameda, K

× Ameda, K

Ameda, K

Search repository
Kobayashi, S

× Kobayashi, S

Kobayashi, S

Search repository
Tanaka, H

× Tanaka, H

Tanaka, H

Search repository
Shibata, T

× Shibata, T

Shibata, T

Search repository
Koyanagi, T

× Koyanagi, T

Koyanagi, T

Search repository
著者 ローマ字
Kakizaki, Hidehiro
書誌情報 International journal of urology

巻 10, 号 11, p. 576-581, 発行日 2003-01-01
ISSN
収録物識別子タイプ ISSN
収録物識別子 0919-8172
DOI
識別子タイプ DOI
関連識別子 10.1046/j.1442-2042.2003.00710.x
リンクURL
内容記述タイプ Other
内容記述 http://www.blackwell-synergy.com/doi/abs/10.1046/j.1442-2042.2003.00710.x | http://www.blackwell-synergy.com/doi/abs/10.1046/j.1442-2042.2003.00710.x
抄録
内容記述タイプ Abstract
内容記述 Backgroud: The therapeutic role of α-blockers in the treatment of voiding disorders due to benign prostatic hyperplasia has been extensively examined. To investigate a possible effect of α1-blocker on urodynamic voiding parameters in patients with neurogenic bladder, we conducted a clinical trial using tamsulosin. Methods: Twenty-four patients (14 men and 10 women) ranging from 24 to 82 years of age (mean age 61 years) with neurogenic bladder were analyzed. Urodynamic studies were performed before and after treatment with 0.4 mg tamsulosin daily for 4 weeks. Results: On uroflowmetry, the average flow rate (from 4.6 ± 3.3 to 6.7 ± 3.0 mL/s, P = 0.04), maximum flow rate (from 9.4 ± 6.8 to 14.1 ± 7.0 mL/s, P = 0.016) and residual urine rate (from 46 ± 29 to 32 ± 21%, P = 0.02) improved significantly. In patients with detrusor contraction during voiding, detrusor opening pressure and detrusor pressure at maximum flow decreased significantly from 69.0 ± 36.2 to 49.2 ± 26.4 cmH2O (P = 0.046) and from 66.7 ± 34.6 to 53.6 ± 26.5 cmH2O (P = 0.007), respectively. On the other hand, in patients with detrusor areflexia, vesical opening pressure (from 78.2 ± 23.4 to 61.6 ± 25.2 cmH2O), or vesical pressure at maximum flow (from 68.6 ± 23.2 to 62.9 ± 25.2 cmH2O) did not change significantly after treatment. Conclusion: Tamsulosin reduces functional urethral resistance during voiding and improves flow rate in patients with neurogenic bladder. It has more beneficial urodynamic effects in patients with detrusor contraction during voiding than in patients with detrusor areflexia.
注記
内容記述タイプ Other
注記 Blackwell Publishing, HIDEHIRO, KAKIZAKI ; KANAME, AMEDA ; SHINYA, KOBAYASHI ; HIROSHI, TANAKA ; TAKASHI, SHIBATA ; TOMOHIKO, KOYANAGI, International journal of urology, 10(11), 2003, 576-581.
資源タイプ
内容記述タイプ Other
資源タイプ text
フォーマット
内容記述タイプ Other
内容記述 application/pdf
ID(XooNIps)
14633081
閲覧数(XooNIps)
ダウンロード数(XooNIps)
745
戻る
0
views
See details
Views

Versions

Ver.1 2023-06-19 13:55:14.395281
Show All versions

Share

Mendeley Twitter Facebook Print Addthis

Cite as

エクスポート

OAI-PMH
  • OAI-PMH JPCOAR 2.0
  • OAI-PMH JPCOAR 1.0
  • OAI-PMH DublinCore
  • OAI-PMH DDI
Other Formats
  • JSON
  • BIBTEX

Confirm


Powered by WEKO3


Powered by WEKO3